According to Utah Medical Products's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.7378. At the end of 2023 the company had a P/S ratio of 6.09.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.09 | -12.75% |
2022 | 6.98 | -6.38% |
2021 | 7.45 | 2.33% |
2020 | 7.28 | -14.96% |
2019 | 8.56 | 16.36% |
2018 | 7.36 | 0.63% |
2017 | 7.31 | 5.02% |
2016 | 6.96 | 27.34% |
2015 | 5.47 | 0.29% |
2014 | 5.45 | 3.2% |
2013 | 5.28 | 64.47% |
2012 | 3.21 | 23.79% |
2011 | 2.60 | -32.98% |
2010 | 3.87 | -5.22% |
2009 | 4.09 | 43.52% |
2008 | 2.85 | -30.09% |
2007 | 4.07 | -9.99% |
2006 | 4.52 | 1.55% |
2005 | 4.45 | 27.91% |
2004 | 3.48 | -20.43% |
2003 | 4.38 | 41.13% |
2002 | 3.10 | 22.14% |
2001 | 2.54 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.80 | -19.72% | ๐บ๐ธ USA |
Teleflex TFX | 3.30 | -30.32% | ๐บ๐ธ USA |
Cooper Companies COO | 4.87 | 2.86% | ๐บ๐ธ USA |
Merit Medical MMSI | 3.47 | -26.81% | ๐บ๐ธ USA |
CONMED CNMD | 1.64 | -65.36% | ๐บ๐ธ USA |